{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T06:24:15Z","timestamp":1778739855356,"version":"3.51.4"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005851","name":"Shahid Beheshti University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005851","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.gene.2021.146113","type":"journal-article","created":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T11:47:47Z","timestamp":1639050467000},"page":"146113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["A comprehensive overview of identified mutations in SARS CoV-2 spike glycoprotein among Iranian patients"],"prefix":"10.1016","volume":"813","author":[{"given":"Solat","family":"Eslami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark C.","family":"Glassy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soudeh","family":"Ghafouri-Fard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gene.2021.146113_b0005","unstructured":"Bernal, J.L., et al., 2021. Effectiveness of COVID-19 vaccines against the B. 1.617. 2 variant. medRxiv."},{"key":"10.1016\/j.gene.2021.146113_b0010","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jpcb.1c01626","article-title":"Structural and dynamical differences in the spike protein RBD in the SARS-CoV-2 Variants B. 1.1. 7 and B. 1.351","author":"Bhattarai","year":"2021","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.gene.2021.146113_b0015","article-title":"Presence of SARS-CoV-2 reactive T cells in COVID-19 patients and healthy donors","author":"Braun","year":"2020","journal-title":"MedRxiv"},{"issue":"2","key":"10.1016\/j.gene.2021.146113_b0020","doi-asserted-by":"crossref","first-page":"e1009373","DOI":"10.1371\/journal.ppat.1009373","article-title":"Transmission of SARS-CoV-2 in domestic cats imposes a narrow bottleneck","volume":"17","author":"Braun","year":"2021","journal-title":"PLoS Pathog."},{"issue":"9","key":"10.1016\/j.gene.2021.146113_b0025","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1002\/jmv.25902","article-title":"Distinct viral clades of SARS-CoV-2: Implications for modeling of viral spread","volume":"92","author":"Brufsky","year":"2020","journal-title":"J. Med.Virol."},{"issue":"24","key":"10.1016\/j.gene.2021.146113_b0030","doi-asserted-by":"crossref","first-page":"2100509","DOI":"10.2807\/1560-7917.ES.2021.26.24.2100509","article-title":"Increased transmissibility and global spread of SARS-CoV-2 variants of concern as at June 2021","volume":"26","author":"Campbell","year":"2021","journal-title":"Eurosurveillance"},{"issue":"1","key":"10.1016\/j.gene.2021.146113_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41421-020-0147-1","article-title":"Comparative genetic analysis of the novel coronavirus (2019-nCoV\/SARS-CoV-2) receptor ACE2 in different populations","volume":"6","author":"Cao","year":"2020","journal-title":"Cell Discovery"},{"key":"10.1016\/j.gene.2021.146113_b0040","doi-asserted-by":"crossref","unstructured":"Cavallo, L., Oliva, R., 2020. D936Y and other mutations in the fusion core of the SARS-CoV-2 spike protein heptad repeat 1 undermine the post-fusion assembly.","DOI":"10.1101\/2020.06.08.140152"},{"issue":"7857","key":"10.1016\/j.gene.2021.146113_b0045","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/s41586-021-03471-w","article-title":"Escape of SARS-CoV-2 501Y. V2 from neutralization by convalescent plasma","volume":"593","author":"Cele","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.gene.2021.146113_b0050","doi-asserted-by":"crossref","unstructured":"Chaudhari, A., et al., 2021. E156G and Arg158, Phe-157\/del mutation in NTD of spike protein in B. 1.617. 2 lineage of SARS-CoV-2 leads to immune evasion through antibody escape. bioRxiv.","DOI":"10.1101\/2021.06.07.447321"},{"key":"10.1016\/j.gene.2021.146113_b0055","doi-asserted-by":"crossref","first-page":"104742","DOI":"10.1016\/j.antiviral.2020.104742","article-title":"The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade","volume":"176","author":"Coutard","year":"2020","journal-title":"Antiviral Res."},{"issue":"7858","key":"10.1016\/j.gene.2021.146113_b0060","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-021-03426-1","article-title":"Increased mortality in community-tested cases of SARS-CoV-2 lineage B. 1.1.7","volume":"593","author":"Davies","year":"2021","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.gene.2021.146113_b0065","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1016\/j.cell.2021.03.055","article-title":"Antibody evasion by the P. 1 strain of SARS-CoV-2","volume":"184","author":"Dejnirattisai","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.gene.2021.146113_b0070","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.27062","article-title":"Preliminary report on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Spike mutation T478K","author":"Di Giacomo","year":"2021","journal-title":"J. Med.Virol."},{"issue":"5","key":"10.1016\/j.gene.2021.146113_b0075","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1093\/nar\/gkh340","article-title":"MUSCLE: multiple sequence alignment with high accuracy and high throughput","volume":"32","author":"Edgar","year":"2004","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"10.1016\/j.gene.2021.146113_b0080","doi-asserted-by":"crossref","DOI":"10.1038\/s41577-021-00510-5","article-title":"SARS-CoV-2 variant evades antibodies whilst maintaining fitness","volume":"21","author":"Flemming","year":"2021","journal-title":"Nature Rev. Immunol."},{"issue":"3","key":"10.1016\/j.gene.2021.146113_b0085","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3390\/v13030392","article-title":"SARS-CoV-2 variant of concern 202012\/01 has about twofold replicative advantage and acquires concerning mutations","volume":"13","author":"Grabowski","year":"2021","journal-title":"Viruses"},{"issue":"12","key":"10.1016\/j.gene.2021.146113_b0090","doi-asserted-by":"crossref","first-page":"e0239566","DOI":"10.1371\/journal.pone.0239566","article-title":"CD8 T cell epitope generation toward the continually mutating SARS-CoV-2 spike protein in genetically diverse human population: implications for disease control and prevention","volume":"15","author":"Guo","year":"2020","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.gene.2021.146113_b0095","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/prot.26042","article-title":"Human SARS CoV-2 spike protein mutations","volume":"89","author":"Guruprasad","year":"2021","journal-title":"Proteins"},{"issue":"7","key":"10.1016\/j.gene.2021.146113_b0100","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41579-021-00573-0","article-title":"SARS-CoV-2 variants, spike mutations and immune escape","volume":"19","author":"Harvey","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.gene.2021.146113_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(21)00068-9","article-title":"SARS-CoV-2 spike E484K mutation reduces antibody neutralisation","author":"Jangra","year":"2021","journal-title":"Lancet Microbe"},{"issue":"7853","key":"10.1016\/j.gene.2021.146113_b0110","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41586-021-03291-y","article-title":"SARS-CoV-2 evolution during treatment of chronic infection","volume":"592","author":"Kemp","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.gene.2021.146113_b0115","doi-asserted-by":"crossref","unstructured":"Kemp, S.A., et al., 2021. Recurrent emergence and transmission of a SARS-CoV-2 Spike deletion H69\/V70.","DOI":"10.2139\/ssrn.3780277"},{"key":"10.1016\/j.gene.2021.146113_b0120","doi-asserted-by":"crossref","DOI":"10.1002\/jcp.30367","article-title":"Higher infectivity of the SARS-CoV-2 new variants is associated with K417N\/T, E484K, and N501Y mutants: An insight from structural data","author":"Khan","year":"2021","journal-title":"J. Cell. Physiol."},{"issue":"6","key":"10.1016\/j.gene.2021.146113_b0125","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/molbev\/msy096","article-title":"MEGA X: molecular evolutionary genetics analysis across computing platforms","volume":"35","author":"Kumar","year":"2018","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.gene.2021.146113_b0130","doi-asserted-by":"crossref","first-page":"104445","DOI":"10.1016\/j.meegid.2020.104445","article-title":"Characterizations of SARS-CoV-2 mutational profile, spike protein stability and viral transmission","volume":"85","author":"Laha","year":"2020","journal-title":"Infect. Gen. Evolut."},{"key":"10.1016\/j.gene.2021.146113_b0135","first-page":"1","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","author":"Lan","year":"2020","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.gene.2021.146113_b0140","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.3390\/v13071192","article-title":"Immune evasion of SARS-CoV-2 emerging variants: what have we learnt so far?","volume":"13","author":"Lazarevic","year":"2021","journal-title":"Viruses"},{"issue":"5","key":"10.1016\/j.gene.2021.146113_b0145","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.cell.2020.07.012","article-title":"The impact of mutations in SARS-CoV-2 spike on viral infectivity and antigenicity","volume":"182","author":"Li","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.gene.2021.146113_b0150","article-title":"Reduced neutralization of SARS-CoV-2 B. 1.617 by vaccine and convalescent serum","author":"Liu","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.gene.2021.146113_b0155","doi-asserted-by":"crossref","unstructured":"Liu, Z., et al., 2020. Landscape analysis of escape variants identifies SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization. Available at SSRN 3725763.","DOI":"10.2139\/ssrn.3725763"},{"issue":"10","key":"10.1016\/j.gene.2021.146113_b0160","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1002\/1873-3468.14076","article-title":"Enhanced binding of the N501Y-mutated SARS-CoV-2 spike protein to the human ACE2 receptor: insights from molecular dynamics simulations","volume":"595","author":"Luan","year":"2021","journal-title":"FEBS Lett."},{"key":"10.1016\/j.gene.2021.146113_b0165","doi-asserted-by":"crossref","unstructured":"Lubinski, B., et al., 2021. Functional evaluation of proteolytic activation for the SARS-CoV-2 variant B. 1.1. 7: role of the P681H mutation. bioRxiv.","DOI":"10.2139\/ssrn.3889709"},{"issue":"20","key":"10.1016\/j.gene.2021.146113_b0170","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1056\/NEJMoa2102214","article-title":"Efficacy of the ChAdOx1 nCoV-19 Covid-19 vaccine against the B. 1.351 variant","volume":"384","author":"Madhi","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.gene.2021.146113_b0175","doi-asserted-by":"crossref","unstructured":"Mishra, A., et al., 2021. Natural infection of SARS-CoV-2 delta variant in Asiatic lions (Panthera leo persica) in India. bioRxiv.","DOI":"10.1101\/2021.07.02.450663"},{"key":"10.1016\/j.gene.2021.146113_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2021.06.006","article-title":"SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity","author":"Motozono","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.gene.2021.146113_b0185","unstructured":"Pearson, C., et al., 2021. Estimates of severity and transmissibility of novel South Africa SARS-CoV-2 variant 501Y. V2."},{"issue":"7852","key":"10.1016\/j.gene.2021.146113_b0190","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41586-020-2895-3","article-title":"Spike mutation D614G alters SARS-CoV-2 fitness","volume":"592","author":"Plante","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.gene.2021.146113_b0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3126\/jbs.v8i1.38449","article-title":"The Delta Plus variant of COVID-19: Will it be the worst nightmare in the SARS-CoV-2 pandemic?","volume":"8","author":"Roy","year":"2021","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.gene.2021.146113_b0200","unstructured":"Saito, A., et al., 2021. SARS-CoV-2 spike P681R mutation enhances and accelerates viral fusion. bioRxiv."},{"issue":"9","key":"10.1016\/j.gene.2021.146113_b0205","doi-asserted-by":"crossref","first-page":"e0249254","DOI":"10.1371\/journal.pone.0249254","article-title":"Large-scale analysis of SARS-CoV-2 spike-glycoprotein mutants demonstrates the need for continuous screening of virus isolates","volume":"16","author":"Schr\u00f6rs","year":"2021","journal-title":"PLoS ONE"},{"key":"10.1016\/j.gene.2021.146113_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(21)01358-1","article-title":"SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness","author":"Sheikh","year":"2021","journal-title":"The Lancet"},{"issue":"1","key":"10.1016\/j.gene.2021.146113_b0215","first-page":"1","article-title":"Serine 477 plays a crucial role in the interaction of the SARS-CoV-2 spike protein with the human receptor ACE2","volume":"11","author":"Singh","year":"2021","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.gene.2021.146113_b0220","doi-asserted-by":"crossref","first-page":"100255","DOI":"10.1016\/j.xcrm.2021.100255","article-title":"Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016","volume":"2","author":"Starr","year":"2021","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.gene.2021.146113_b0225","article-title":"SARS-CoV-2 and SARS-CoV spike-RBD structure and receptor binding comparison and potential implications on neutralizing antibody and vaccine development","author":"Sun","year":"2020","journal-title":"Biorxiv"},{"issue":"9","key":"10.1016\/j.gene.2021.146113_b0230","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1016\/j.cell.2021.03.029","article-title":"Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein","volume":"184","author":"Suryadevara","year":"2021","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.gene.2021.146113_b0235","first-page":"512","article-title":"Estimation of the number of nucleotide substitutions in the control region of mitochondrial DNA in humans and chimpanzees","volume":"10","author":"Tamura","year":"1993","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.gene.2021.146113_b0240","unstructured":"Tomkins-Tinch, C.H., et al., Detection of the recurrent substitution Q677H in the spike protein of SARS-CoV-2 in cases descended from the lineage B. 1.429."},{"key":"10.1016\/j.gene.2021.146113_b0245","unstructured":"TWR, C.A.P., et al., 2021. Estimates of severity and transmissibility of novel South Africa SARS-CoV-2 variant501Y. V2. Centre for Mathematical Modelling of Infectious Diseases."},{"key":"10.1016\/j.gene.2021.146113_b0250","unstructured":"US Food and Drug Administration. Fact sheet for health care providers emergency use authorization (EUA) of bamlanivimab and etesevimab. Available at: https:\/\/www.fda.gov\/media\/145802\/download."},{"key":"10.1016\/j.gene.2021.146113_b0255","doi-asserted-by":"crossref","unstructured":"Venkatakrishnan, A., et al., 2021. Antigenic minimalism of SARS-CoV-2 is linked to surges in COVID-19 community transmission and vaccine breakthrough infections. medRxiv.","DOI":"10.21203\/rs.3.rs-555451\/v1"},{"key":"10.1016\/j.gene.2021.146113_b0260","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3389\/fmicb.2020.00298","article-title":"Subunit vaccines against emerging pathogenic human coronaviruses","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Microbiol."},{"issue":"4","key":"10.1016\/j.gene.2021.146113_b0265","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1016\/j.ygeno.2021.05.006","article-title":"Vaccine-escape and fast-growing mutations in the United Kingdom, the United States, Singapore, Spain, India, and other COVID-19-devastated countries","volume":"113","author":"Wang","year":"2021","journal-title":"Genomics"},{"issue":"5","key":"10.1016\/j.gene.2021.146113_b0270","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.chom.2021.04.007","article-title":"Increased resistance of SARS-CoV-2 variant P. 1 to antibody neutralization","volume":"29","author":"Wang","year":"2021","journal-title":"Cell host & microbe"},{"key":"10.1016\/j.gene.2021.146113_b0275","doi-asserted-by":"crossref","unstructured":"West, Jr., A.P., et al., 2021. Detection and characterization of the SARS-CoV-2 lineage B. 1.526 in New York. bioRxiv.","DOI":"10.1038\/s41467-021-25168-4"},{"issue":"4","key":"10.1016\/j.gene.2021.146113_b0280","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/s41591-021-01285-x","article-title":"SARS-CoV-2 501Y. V2 escapes neutralization by South African COVID-19 donor plasma","volume":"27","author":"Wibmer","year":"2021","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.gene.2021.146113_b0285","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/s41423-020-0374-2","article-title":"Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein","volume":"17","author":"Xia","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.gene.2021.146113_b0290","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa237","article-title":"In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","author":"Yao","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.gene.2021.146113_b0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-19808-4","article-title":"SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity","volume":"11","author":"Zhang","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.gene.2021.146113_b0300","doi-asserted-by":"crossref","unstructured":"Zhang, X., et al., 2021. Inhibitor screening of Spike variants reveals the heterogeneity of neutralizing antibodies to COVID-19 infection and vaccination. medRxiv.","DOI":"10.1101\/2021.05.15.21257254"},{"key":"10.1016\/j.gene.2021.146113_b0305","doi-asserted-by":"crossref","unstructured":"Zhou, Z.-J., Qiu, Y., Ge, X.-Y., 2020. Characterization of the substitution hotspots in SARS-CoV-2 genome using BioAider and detection of a SR-rich region in N protein providing further evidence of its animal origin. bioRxiv.","DOI":"10.1101\/2020.06.04.135293"}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111921007083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111921007083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T16:47:02Z","timestamp":1759855622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111921007083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":61,"alternative-id":["S0378111921007083"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2021.146113","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comprehensive overview of identified mutations in SARS CoV-2 spike glycoprotein among Iranian patients","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2021.146113","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"146113"}}